About AlphaSIP
AlphaSIP is a company based in Zaragoza (Spain) founded in 2008. AlphaSIP operates in a competitive market with competitors including Opentrons, Tecan, Andrew Alliance, LabCyte and Entopsis, among others.
- Headquarter Zaragoza, Spain
- SectorsHealthcareTechnology
- Email••••••••
- Website alphasip.es
- Social LinkedIn X Facebook
- Latest Funding Round$3.96M (USD), Grant
Jul 2018
- InvestorsEuropean Union
& 1 more
Funding Insights of AlphaSIP
- Total Rounds 4
- Last Round Grant — $3.96M
- First Round $63,090
(Oct 2014)
- Investors Count 2
All 4 funding rounds of AlphaSIP with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2018 | $3.96M | Grant | – | – | |
| Nov 2015 | $3.73M | Grant | – | – | |
| Feb 2015 | $56,042 | Grant | – | – | |
| Oct 2014 | $63,090 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in AlphaSIP
AlphaSIP has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for AlphaSIP
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of AlphaSIP
3 dated milestones of AlphaSIP across 10 years, from founding to its latest funding, stage changes and deals.
- Founded AlphaSIP is founded.
- Funding First funding round of $63K.
- Funding Latest funding round, Grant, of $4.0M.
Competitors of AlphaSIP
AlphaSIP operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Opentrons, Tecan, Andrew Alliance, LabCyte and Entopsis, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| opentrons.com | 2013 | Brooklyn, United States | $240.56M | 177 | Pipetting robots for laboratory automation are developed. | |
| tecan.com | 1980 | Mannedorf, Switzerland | – | – | Automated laboratory instruments, robotics, and diagnostic solutions are provided. | |
| andrewalliance.com | 2011 | Vernier, Switzerland | $14.03M | 5 | Provider of automated liquid handling tools and software for scientific labs | |
| labcyte.com | 2000 | Sunnyvale, United States | $33.39M | 184 | Acoustic liquid handling is developed for life science research. | |
| entopsis.com | 2011 | Miami, United States | $1.05M | – | Diagnostic devices for health monitoring are developed using specialized slides. | |
| tethis-lab.com | 2004 | Milan, Italy | $15.33M | – | Automated solutions for liquid biopsy processing are provided. | |
| ginolis.com | 2010 | Oulunsalo, Finland | $2.41M | – | Liquid handling and lab automation robots | |
| scienion.com | 2000 | Berlin, Germany | $5.67M | 114 | Non-contact dispensing solutions for genomics and proteomics are provided. | |
| gna-bio.com | 2010 | Planegg, Germany | $20.2M | 29 | Instruments and assays for molecular pathogen detection are developed. | |
| nanovation-gs.com | 2014 | Haifa, Israel | $5.9M | – | Nanomaterial-based sensors for respiratory monitoring devices are developed. |
Detailed competitors of AlphaSIP
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AlphaSIP
Websites that share an audience with AlphaSIP (alphasip.es).
Websites whose visitors overlap most with AlphaSIP. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Similar companies to AlphaSIP
10 companies that operate in the same segment as AlphaSIP (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AlphaSIP
AlphaSIP was founded in 2008 and raised its 1st funding round 6 years after it was founded.
AlphaSIP is headquartered in Zaragoza, Spain. It is registered at Zaragoza, Aragon, Spain.
AlphaSIP was founded in 2008 in Zaragoza, Spain, and operates in the molecular diagnostics sector. Molecular diagnostic chips are designed, developed, and produced using field-effect transistor sensors based on nanotubes to detect conductivity changes for immediate illness identification. Focus is placed on three kits: DrugSIP for rapid drug testing, PneumoSIP for pneumococci detection, and TromboChip for deep venous thrombosis assessment. Operations support advancements in personalized medicine through these biosensor technologies.
AlphaSIP's top competitors include Opentrons, Tecan and Andrew Alliance.
AlphaSIP has 2 investors. Key investors include European Union, and EIC Fund.